Quantification of the contribution of GLP-1 to mediating insulinotropic effects of DPP-4 inhibition with vildagliptin in healthy subjects and type 2-diabetic patients using exendin [9-39] as a GLP-1 receptor antagonist.

Michael A Nauck, J Kind, Lars D Köthe, Jens Juul Holst, Carolyn F. Deacon, M Broschag, YL He, L Kjems, J. Foley

35 Citationer (Scopus)

Fingeraftryk

Dyk ned i forskningsemnerne om 'Quantification of the contribution of GLP-1 to mediating insulinotropic effects of DPP-4 inhibition with vildagliptin in healthy subjects and type 2-diabetic patients using exendin [9-39] as a GLP-1 receptor antagonist.'. Sammen danner de et unikt fingeraftryk.

Medicin og biovidenskab